JP2005511538A5 - - Google Patents

Download PDF

Info

Publication number
JP2005511538A5
JP2005511538A5 JP2003536265A JP2003536265A JP2005511538A5 JP 2005511538 A5 JP2005511538 A5 JP 2005511538A5 JP 2003536265 A JP2003536265 A JP 2003536265A JP 2003536265 A JP2003536265 A JP 2003536265A JP 2005511538 A5 JP2005511538 A5 JP 2005511538A5
Authority
JP
Japan
Prior art keywords
isomer
mixture
day
isomeric
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003536265A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005511538A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2002/001560 external-priority patent/WO2003033527A2/en
Publication of JP2005511538A publication Critical patent/JP2005511538A/ja
Publication of JP2005511538A5 publication Critical patent/JP2005511538A5/ja
Withdrawn legal-status Critical Current

Links

JP2003536265A 2001-10-19 2002-10-17 シクロスポリン類似体混合物及びそれらの免疫調節剤としての使用 Withdrawn JP2005511538A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34620101P 2001-10-19 2001-10-19
PCT/CA2002/001560 WO2003033527A2 (en) 2001-10-19 2002-10-17 Cyclosporine analogue mixtures and their use as immunomodulating agents

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2009140608A Division JP5272140B2 (ja) 2001-10-19 2009-06-11 シクロスポリン類似体混合物及びそれらの免疫調節剤としての使用
JP2010151859A Division JP2011006417A (ja) 2001-10-19 2010-07-02 シクロスポリン類似体混合物及びそれらの免疫調整剤としての使用

Publications (2)

Publication Number Publication Date
JP2005511538A JP2005511538A (ja) 2005-04-28
JP2005511538A5 true JP2005511538A5 (cg-RX-API-DMAC7.html) 2006-01-12

Family

ID=23358378

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2003536265A Withdrawn JP2005511538A (ja) 2001-10-19 2002-10-17 シクロスポリン類似体混合物及びそれらの免疫調節剤としての使用
JP2009140608A Expired - Lifetime JP5272140B2 (ja) 2001-10-19 2009-06-11 シクロスポリン類似体混合物及びそれらの免疫調節剤としての使用
JP2010151859A Pending JP2011006417A (ja) 2001-10-19 2010-07-02 シクロスポリン類似体混合物及びそれらの免疫調整剤としての使用
JP2013017448A Pending JP2013136597A (ja) 2001-10-19 2013-01-31 シクロスポリン類似体混合物及びそれらの免疫調整剤としての使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2009140608A Expired - Lifetime JP5272140B2 (ja) 2001-10-19 2009-06-11 シクロスポリン類似体混合物及びそれらの免疫調節剤としての使用
JP2010151859A Pending JP2011006417A (ja) 2001-10-19 2010-07-02 シクロスポリン類似体混合物及びそれらの免疫調整剤としての使用
JP2013017448A Pending JP2013136597A (ja) 2001-10-19 2013-01-31 シクロスポリン類似体混合物及びそれらの免疫調整剤としての使用

Country Status (38)

Country Link
US (2) US20110092669A1 (cg-RX-API-DMAC7.html)
EP (2) EP1436322B1 (cg-RX-API-DMAC7.html)
JP (4) JP2005511538A (cg-RX-API-DMAC7.html)
KR (1) KR100992850B1 (cg-RX-API-DMAC7.html)
CN (1) CN100344648C (cg-RX-API-DMAC7.html)
AR (1) AR036853A1 (cg-RX-API-DMAC7.html)
AT (1) ATE401339T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002331510B2 (cg-RX-API-DMAC7.html)
BE (1) BE2022C547I2 (cg-RX-API-DMAC7.html)
BR (1) BR0213659A (cg-RX-API-DMAC7.html)
CA (2) CA2727642C (cg-RX-API-DMAC7.html)
CO (1) CO5570682A2 (cg-RX-API-DMAC7.html)
CY (2) CY1108410T1 (cg-RX-API-DMAC7.html)
DE (1) DE60227686D1 (cg-RX-API-DMAC7.html)
DK (1) DK1436322T3 (cg-RX-API-DMAC7.html)
EC (3) ECSP045059A (cg-RX-API-DMAC7.html)
ES (1) ES2310604T3 (cg-RX-API-DMAC7.html)
FI (1) FIC20220041I1 (cg-RX-API-DMAC7.html)
FR (1) FR22C1051I2 (cg-RX-API-DMAC7.html)
HR (1) HRP20040353B1 (cg-RX-API-DMAC7.html)
IL (2) IL160762A0 (cg-RX-API-DMAC7.html)
LT (1) LTC1436322I2 (cg-RX-API-DMAC7.html)
MA (1) MA26337A1 (cg-RX-API-DMAC7.html)
ME (1) ME00487B (cg-RX-API-DMAC7.html)
MX (1) MXPA04003624A (cg-RX-API-DMAC7.html)
MY (1) MY187182A (cg-RX-API-DMAC7.html)
NL (1) NL301200I2 (cg-RX-API-DMAC7.html)
NO (2) NO331745B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ531945A (cg-RX-API-DMAC7.html)
PL (1) PL210697B1 (cg-RX-API-DMAC7.html)
PT (1) PT1436322E (cg-RX-API-DMAC7.html)
PY (2) PY0225477A (cg-RX-API-DMAC7.html)
RU (1) RU2337106C2 (cg-RX-API-DMAC7.html)
SI (1) SI1436322T1 (cg-RX-API-DMAC7.html)
TN (1) TNSN04069A1 (cg-RX-API-DMAC7.html)
UY (1) UY27502A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003033527A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200402270B (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1436322T3 (da) * 2001-10-19 2008-11-03 Isotechnika Inc Blandinger af cyclosporinanaloger og deres anvendelse som immunmodulerende midler
HRP20070058B1 (hr) 2001-10-19 2014-05-23 Isotechnika Inc. Sinteza ciklosporinskih analoga
CA2518265A1 (en) 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
TW200505946A (en) * 2003-04-08 2005-02-16 Hoffmann La Roche Process for preparation of cyclosporin a analog
US7378391B2 (en) 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
JP2008514702A (ja) 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド 新規シクロスポリン類似体およびそれらの薬学的使用
WO2006041631A2 (en) 2004-10-06 2006-04-20 Amr Technology, Inc. Novel cyclosporin alkynes and their utility as pharmaceutical agents
TW200635954A (en) * 2004-12-17 2006-10-16 Isotechnika Inc Metabolites of cyclosporin analogs
KR101273681B1 (ko) * 2005-10-26 2013-06-25 아스텔라스세이야쿠 가부시키가이샤 신규 시클릭 펩티드 화합물
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
EP2150269B1 (en) * 2007-05-02 2012-11-21 Astellas Pharma Inc. New cyclic peptide compounds
JP5668476B2 (ja) 2007-10-08 2015-02-12 オーリニア・ファーマシューティカルズ・インコーポレイテッドAurinia Pharmaceuticals Inc. カルシニューリン阻害剤またはmTOR阻害剤を含む眼科用組成物
RU2361604C1 (ru) * 2007-10-29 2009-07-20 Федеральное агентство по высокотехнологичной медицинской помощи Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии" (ФГУ УрНИИДВиИ Росмедтехнологий) Способ лечения атопического дерматита
EP2440185B1 (en) 2009-06-09 2015-04-08 Aurinia Pharmaceuticals Inc. Topical drug delivery systems for ophthalmic use
GB0912584D0 (en) * 2009-07-20 2009-08-26 Ucl Business Plc Cyclosporin conjugates
AU2011342284C1 (en) 2010-12-15 2017-07-13 Contravir Pharmaceuticals, Inc. Cyclosporine analogue molecules modified at amino acid 1 and 3
GB201222455D0 (en) * 2012-12-13 2013-01-30 Perioc Ltd Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
EP3549051A4 (en) * 2016-11-30 2020-04-29 Schrodinger, Inc. GRAPHIC USER INTERFACE FOR CALCULATING CHEMICAL TRANSITIONAL STATES
CA3045944A1 (en) 2016-12-07 2018-06-14 Progenity, Inc. Gastrointestinal tract detection methods, devices and systems
WO2018106928A1 (en) 2016-12-08 2018-06-14 Contravir Pharmaceuticals, Inc. Treatment and prevention of hbv diseases by cyclosporine analogue molecules modified at amino acides 1 and 3
US11523772B2 (en) 2016-12-14 2022-12-13 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with an immunosuppressant
US10286036B2 (en) * 2017-05-12 2019-05-14 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
US20230041197A1 (en) 2018-06-20 2023-02-09 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immunomodulator
CA3172535A1 (en) * 2020-03-26 2021-09-30 Ching-Pong Mak Cyclophilin inhibitors and uses thereof
EP4201952A1 (en) 2021-12-21 2023-06-28 Curia Spain, S.A.U. Process for the controlled synthesis of voclosporin
WO2024052941A1 (en) * 2022-09-09 2024-03-14 Dr. Reddy's Laboratories Limited Improved process for the preparation of voclosporin
IT202300001056A1 (it) * 2023-01-25 2024-07-25 Procos Spa Nuovo processo per la preparazione di voclosporina amorfa
IT202300001116A1 (it) * 2023-01-25 2024-07-25 Indena Spa Processo per la preparazione di un intermedio utile per la sintesi di voclosporina
WO2025119925A1 (en) 2023-12-05 2025-06-12 Medichem, S.A. Process for preparing voclosporin
IT202300028041A1 (it) * 2023-12-27 2025-06-27 Indena Spa Processo per la preparazione di voclosporina

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4278545A (en) * 1979-09-12 1981-07-14 The Bendix Corporation Apparatus for separating solids and liquid components
CH670644A5 (cg-RX-API-DMAC7.html) * 1986-12-18 1989-06-30 Lonza Ag
US5162540A (en) * 1986-12-18 1992-11-10 Lonza Ltd. Process for the production of (+) biotin
ATE95193T1 (de) * 1987-06-17 1993-10-15 Sandoz Ag Cyclosporine und deren benutzung als arzneimittel.
US5972630A (en) * 1991-08-19 1999-10-26 Dade Behring Marburg Gmbh Homogeneous immunoassays using enzyme inhibitors
GB9204466D0 (en) * 1992-03-02 1992-04-15 Sandoz Ltd Improvements in or relating to organic compounds
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
DK0869810T3 (da) * 1996-06-19 2005-02-07 Novartis Ag Cyclosporinholdige blöde kapselpræparater
US5939406A (en) * 1997-07-21 1999-08-17 Wisconsin Alumni Research Foundation 18-substituted-19-nor-vitamin D compounds
DE69832984T2 (de) * 1997-10-08 2006-09-21 Isotechnika, Inc., Edmonton DEUTERIERtE und undeuterierte CYCLOSPORIN-ANALOGA UND IHRE VERWENDUNG ALS IMMUNMODULIERENDE AGENtIEN
HRP20070058B1 (hr) * 2001-10-19 2014-05-23 Isotechnika Inc. Sinteza ciklosporinskih analoga
DK1436322T3 (da) * 2001-10-19 2008-11-03 Isotechnika Inc Blandinger af cyclosporinanaloger og deres anvendelse som immunmodulerende midler

Similar Documents

Publication Publication Date Title
RU2337106C2 (ru) Смесь аналогов циклоспорина и ее применение в качестве иммуномодулирующего агента
JP5536016B2 (ja) 効果的な医薬の使用法及び副作用発現の防御に関する方法
JP3942641B2 (ja) サイクロスポリンaおよび40―o―(2―ヒドロキシエチル)―ラパマイシンを含む移植拒絶、自己免疫疾患または炎症性状態の処置用医薬組成物
BE1009856A5 (fr) Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule.
ES2216141T3 (es) Composiciones farmaceuticas de micofenolato con recubrimiento enterico.
US20200360324A1 (en) Compounds and Dosage Regimen for Use in the Prevention or Treatment of Chronic Inflammatory and/or Autoimmune Diseases
JP2019123738A (ja) ジアルキルフマレート含有薬剤調合物
RU2204387C2 (ru) Фармацевтические композиции
PT2193788E (pt) Composições farmacêuticas compreendendo dióxido de silício coloidal
JP2023085437A5 (cg-RX-API-DMAC7.html)
JP4153563B2 (ja) 医薬組成物
US20190151403A1 (en) Novel cyclosporin derivatives and uses thereof
JPWO1998037875A1 (ja) 医薬組成物
TW200522975A (en) Pharmaceutical composition for use in the treatment of an inflammatory autoimmune disease or condition
CN100427097C (zh) 霉酚酸、其盐或前体药物的胃肠外制剂
CN109803648A (zh) 可逆保护的硫醇化亲电脂肪酸作为前药
JP4609877B2 (ja) 慢性拒絶反応抑制剤
Kuiper et al. Cyclosporine-induced anaphylaxis
JP2000212080A (ja) 勃起機能不全改善剤
Johnson et al. Use of cyclosporine in neurological autoimmune disease?
ES2362489T3 (es) Método para usar eficazmente un medicamento y método concerniente a la prevención de efectos secundarios.
JPWO2009054463A1 (ja) 親油性il−2産生抑制物質含有医薬組成物
CZ847488A3 (en) Process for preparing cyclosporin a
JPH11501916A (ja) あるシスチン誘導体の薬理学的使用
KR20000005360A (ko) 미코페놀레이트의 장용성 약제 조성물